These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 2683303)
1. Ultrasonographic changes in the normal and malignant prostate after definitive radiotherapy. Egawa S; Carter SS; Wheeler TM; Scardino PT Urol Clin North Am; 1989 Nov; 16(4):741-9. PubMed ID: 2683303 [TBL] [Abstract][Full Text] [Related]
2. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy. Do T; Parker RG; Do C; Tran L; Do L; Dolkar D Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297 [TBL] [Abstract][Full Text] [Related]
4. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma. Crook JM; Bahadur YA; Robertson SJ; Perry GA; Esche BA Cancer; 1997 Jan; 79(1):81-9. PubMed ID: 8988730 [TBL] [Abstract][Full Text] [Related]
6. Ultrasound-guided implantation techniques in treatment of prostate cancer. Carter SS; Torp-Pedersen ST; Holm HH Urol Clin North Am; 1989 Nov; 16(4):751-62. PubMed ID: 2683304 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of digital rectal examination after radiotherapy for prostate cancer. Johnstone PA; McFarland JT; Riffenburgh RH; Amling CL J Urol; 2001 Nov; 166(5):1684-7. PubMed ID: 11586202 [TBL] [Abstract][Full Text] [Related]
8. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. King CR; McNeal JE; Gill H; Presti JC Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152 [TBL] [Abstract][Full Text] [Related]
9. Pathologic basis of the sonographic appearance of the normal and malignant prostate. Shinohara K; Scardino PT; Carter SS; Wheeler TM Urol Clin North Am; 1989 Nov; 16(4):675-91. PubMed ID: 2683298 [TBL] [Abstract][Full Text] [Related]
10. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results. Gelet A; Chapelon JY; Bouvier R; Pangaud C; Lasne Y J Urol; 1999 Jan; 161(1):156-62. PubMed ID: 10037389 [TBL] [Abstract][Full Text] [Related]
11. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings. Rouvière O; Valette O; Grivolat S; Colin-Pangaud C; Bouvier R; Chapelon JY; Gelet A; Lyonnet D Urology; 2004 May; 63(5):922-7. PubMed ID: 15134982 [TBL] [Abstract][Full Text] [Related]
12. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Pucar D; Hricak H; Shukla-Dave A; Kuroiwa K; Drobnjak M; Eastham J; Scardino PT; Zelefsky MJ Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):62-9. PubMed ID: 17707266 [TBL] [Abstract][Full Text] [Related]
13. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment. Aus G Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397 [TBL] [Abstract][Full Text] [Related]